comparemela.com

Prnewswire Children National Hospital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The Children s National Hospital Rare Disease Institute And Takeda Partner To Standardize Care For Patients With Rare Diseases

The Children s National Hospital Rare Disease Institute And Takeda Partner To Standardize Care For Patients With Rare Diseases A five-year commitment from Takeda will help Children s National launch a first-of-its-kind rare disease clinical protocol program. News provided by Share this article Share this article WASHINGTON and CAMBRIDGE, Mass., March 1, 2021 /PRNewswire/ Children s National Hospital and Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) ( Takeda ) today announced the creation of the Rare Disease Clinical Activity Protocols (Rare-CAP) program, which will establish a networked system for the development, dissemination and curation of protocols to help standardize the process of diagnosis and care for patients with rare diseases.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.